Previously published EOC risk loci confirmed by the OncoArray meta-analysis at P < 5 × 10−8 (ref. 23)a,b
Locus | Lead SNP | Phenotype | Effect allele | EAF | OR (95% CI)c | P | Ref. |
---|---|---|---|---|---|---|---|
1p34.3 | rs58722170 | Serous | C | 0.22 | 1.10 (1.07–1.13) | 1.4E−09 | 25 |
2q14.1 | rs752590 | Mucinous | G | 0.21 | 1.30 (1.21–1.39) | 2.2E−12 | 53 |
2q31.1 | rs711830 | Mucinous | A | 0.32 | 1.27 (1.20–1.35) | 1.1E−14 | 53 |
2q31.1 | rs6755777 | Serous | T | 0.32 | 1.12 (1.09–1.15) | 2.7E−15 | 28 |
3q25.31 | rs62274041 | HGSOC | G | 0.05 | 1.57 (1.48–1.66) | 2.1E−57 | 22 |
5p15.33 | rs10069690 | Serous | T | 0.26 | 1.13 (1.09–1.17) | 1.5E−12 | 37 |
5p15.33 | rs7705526 | S. borderline | A | 0.33 | 1.38 (1.29–1.48) | 5.5E−19 | 37 |
8q21.13 | rs76837345 | HGSOC | G | 0.07 | 1.20 (1.13–1.28) | 9.0E−10 | 26 |
8q24.21 | rs1400482 | Serous | G | 0.87 | 1.23 (1.19–1.28) | 7.4E−26 | 28 |
9p22.2 | rs10962692 | HGSOC | G | 0.80 | 1.36 (1.30–1.42) | 1.4E−47 | 22 |
9q34.2 | rs8176685 | HGSOC | G | 0.19 | 1.15 (1.10–1.19) | 5.2E−12 | 25 |
10p12.31 | rs144962376 | Serous | TCCCT | 0.31 | 1.10 (1.06–1.13) | 6.6E−09 | 26 |
17q12 | rs7405776 | Serous | G | 0.41 | 1.10 (1.07–1.14) | 1.9E−10 | 35 |
17q12 | rs11651755 | Clear cell | C | 0.49 | 0.79 (0.73–0.86) | 6.8E−09 | 35 |
17q21.31 | rs7207826 | Serous | C | 0.27 | 1.14 (1.10–1.18) | 1.2E−14 | 36 |
17q21.32 | rs1879586 | HGSOC | G | 0.18 | 1.15 (1.10–1.19) | 2.5E−12 | 26 |
19p13.11 | rs4808075 | HGSOC | C | 0.30 | 1.20 (1.16–1.24) | 3.3E−24 | 29 |
19q13.2 | rs688187 | Mucinous | A | 0.31 | 1.43 (1.33–1.53) | 1.2E−22 | 53 |
In Han Chinese ancestry populations only | |||||||
9q22.33 | rs1413299 | Serous | C | 0.40 | 1.53 (1.25–1.86) | 1.9E−08 | 24 |
10p11.21 | rs1192691 | Serous | A | 0.36 | 0.81 (0.70–0.95) | 2.6E−08 | 24 |